Immediate Impact
64 standout
Citing Papers
Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers
2024 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout
Works of Feng Tai being referenced
PL3.1 A phase 1, open-label, perioperative study of ivosidenib (AG-120) and vorasidenib (AG-881) in recurrent, IDH1-mutant, low-grade glioma: results from cohort 1
2019
Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Feng Tai | 34 | 121 | 140 | 193 | 34 | 505 | |
| Hideo Niwa | 55 | 15 | 22 | 193 | 31 | 512 | |
| Yuxi Sun | 23 | 49 | 28 | 118 | 23 | 443 | |
| Won‐Sang Park | 6 | 13 | 57 | 184 | 14 | 574 | |
| Keishi Tada | 17 | 6 | 135 | 127 | 20 | 538 | |
| Heather A. Long | 51 | 6 | 38 | 233 | 19 | 530 | |
| Mengke Liu | 51 | 36 | 92 | 183 | 25 | 488 | |
| Guoying Feng | 32 | 10 | 79 | 154 | 45 | 512 | |
| Qi Deng | 40 | 67 | 27 | 161 | 34 | 418 | |
| Yizhou Hu | 66 | 9 | 12 | 193 | 27 | 464 | |
| Ming Zhao | 25 | 48 | 45 | 113 | 20 | 471 |
All Works
Login with ORCID to disown or claim papers
Loading papers...